Therefore, this scenario may partially elucidate why selective COX-2 inhibitors show a heightened cardiovascular risk signal, where a greater COX-2 receptor occupancy correlates with an increased likelihood of adverse cardiovascular events, primarily cardiac disorders and vascular disorders. The gene discussed is PTGS2; the disease is vascular disorder.